1.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CHRS Giù?
Forum
Previsione
Coherus Oncology Inc Azioni (CHRS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
34.94%
10.25
|
7.599 | 54.14 | 70.77 | 64.98 |
Cost Of Revenue |
27.97%
3.395
|
2.653 | 33.86 | 20.74 | 28.37 |
Gross Profit |
38.68%
6.859
|
4.946 | 20.29 | 50.03 | 36.61 |
|
3.90%
52.34
|
50.38 | 62.53 | 56.42 | 57.12 |
Interest Income/Expense |
5.91%
2.277
|
2.15 | 5.346 | 5.362 | 5.334 |
Benefits Costs and Expenses |
0.22%
55.12
|
55.00 | 104.84 | 81.53 | 77.90 |
Costs And Expenses |
5.10%
55.74
|
53.03 | 96.39 | 77.16 | 85.49 |
Depreciation and Amortization |
2.87%
1.016
|
1.046 | 1.033 | 1.549 | 1.187 |
Operating Income/Loss |
0.11%
-45.49
|
-45.44 | -42.25 | -6.387 | -20.51 |
Income/Loss From Continuing Operations Before Tax |
5.35%
-44.86
|
-47.40 | -50.70 | -10.75 | -12.92 |
Income/Loss From Continuing Operations After Tax |
5.35%
-44.86
|
-47.40 | -50.70 | -10.75 | -12.92 |
Income/Loss From Discontinued Operations, Net Of Tax |
3,836%
342.63
|
-9.171 | - | - | - |
|
626.38%
297.77
|
-56.57 | -50.70 | -10.75 | -12.92 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.19%
116.08
|
115.86 | 0.2903 | 115.21 | 114.82 |
Diluted Average Shares |
0.19%
116.08
|
115.86 | -11.73 | 115.21 | 114.82 |
Basic Earnings Per Share |
624.49%
2.57
|
-0.49 | -0.44 | -0.09 | -0.11 |
Diluted Earnings Per Share |
624.49%
2.57
|
-0.49 | -0.40 | -0.09 | -0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):